1
|
Neganova M, Liu J, Aleksandrova Y, Vasilieva N, Semakov A, Yandulova E, Sukocheva O, Balakin K, Klochkov S, Fan R. Development of Neuroprotective Agents for the Treatment of Alzheimer's Disease using Conjugates of Serotonin with Sesquiterpene Lactones. Curr Med Chem 2024; 31:529-551. [PMID: 36437724 DOI: 10.2174/0929867330666221125105253] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/22/2022] [Revised: 09/01/2022] [Accepted: 10/19/2022] [Indexed: 11/29/2022]
Abstract
BACKGROUND Sesquiterpene lactones are secondary plant metabolites with a wide variety of biological activities. The process of lactone conjugation to other pharmacophores can increase the efficacy and specificity of the conjugated agent effect on molecular targets in various diseases, including brain pathologies. Derivatives of biogenic indoles, including neurotransmitter serotonin, are of considerable interest as potential pharmacophores. Most of these compounds have neurotropic activity and, therefore, can be used in the synthesis of new drugs with neuroprotective properties. AIM The aim of this experimental synthesis was to generate potential treatment agents for Alzheimer's disease using serotonin conjugated with natural sesquiterpene lactones. METHODS Three novel compounds were obtained via the Michael reaction and used for biological testing. The obtained conjugates demonstrated complex neuroprotective activities. Serotonin conjugated to isoalantolactone exhibited strong antioxidant and mitoprotective activities. RESULTS The agent was also found to inhibit β-site amyloid precursor protein cleaving enzyme 1 (BACE-1), prevent the aggregation of β-amyloid peptide 1-42, and protect SH-SY5Y neuroblastoma cells from neurotoxins such as glutamate and H2O2. In a transgenic animal model of Alzheimer's disease (5xFAD line), the conjugated agent restored declined cognitive functions and improved learning and memory. CONCLUSION In conclusion, the obtained results indicate that serotonin conjugates to sesquiterpene lactones are promising agents for the treatment of symptoms associated with Alzheimer's disease.
Collapse
Affiliation(s)
- Margarita Neganova
- Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Erqi, Zhengzhou, China
- Institute of Physiologically Active Compounds of Russian Academy of Sciences, Chernogolovka, Russia
| | - Junqi Liu
- Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Erqi, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| | - Yulia Aleksandrova
- Institute of Physiologically Active Compounds of Russian Academy of Sciences, Chernogolovka, Russia
| | - Natalia Vasilieva
- Institute of Physiologically Active Compounds of Russian Academy of Sciences, Chernogolovka, Russia
| | - Alexey Semakov
- Institute of Physiologically Active Compounds of Russian Academy of Sciences, Chernogolovka, Russia
| | - Ekaterina Yandulova
- Institute of Physiologically Active Compounds of Russian Academy of Sciences, Chernogolovka, Russia
| | - Olga Sukocheva
- Discipline of Health Sciences, College of Nursing and Health Sciences, Flinders University, Bedford Park, South Australia, Australia
| | - Konstantin Balakin
- Moscow Institute of Physics and Technology (National Research University), Dolgoprudny, Russia
| | - Sergey Klochkov
- Institute of Physiologically Active Compounds of Russian Academy of Sciences, Chernogolovka, Russia
| | - Ruitai Fan
- Department of Radiation Oncology, The First Affiliated Hospital of Zhengzhou University, Erqi, Zhengzhou, China
- Cancer Center, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, China
| |
Collapse
|
2
|
Khaziev R, Shtyrlin N, Pavelyev R, Nigmatullin R, Gabbasova R, Grishaev D, Shtro A, Galochkina A, Nikolaeva Y, Vinogradova T, Manicheva O, Dogonadze M, Gnezdilov O, Sokolovich E, Yablonskiy P, Balakin K, Shtyrlin Y. Synthesis and Antimicrobial Activity of Adamantyl Substituted Pyridoxine Derivatives. LETT DRUG DES DISCOV 2019. [DOI: 10.2174/1570180816666190911150705] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
Background:
Adamantane derivatives possess multiple pharmacological activities such
as antiviral, anticancer, antimycobacterial, antidiabetic, antiparkinsonian and others. The interest of
medicinal chemists in adamantane compounds is due to their unique spatial structure, high lipophilicity,
and carbon cage rigidity. As a result, these molecules can easily penetrate biological lipid
membranes and often have unique target-specific activity profile. Another pharmacophore studied in
this work is pyridoxine (vitamin B6). Pyridoxine plays highly important roles in living cells as a key
cofactor of many enzymes. On the other hand, its molecular scaffold is a valuable structural platform
which has led to the development of several launched drugs (Pyritinol, Pirisudanol, Cycletanine,
Mangafodipir) and a wide number of preclinical and clinical drug candidates.
Objective:
The objective of this study is a synthesis of pyridoxine-adamantane and pyridoxinecyclooctane
dipharmacophore molecules. The underlying idea was to assess the antibacterial and
antiviral potential of such dipharmacophores, based on multiple examples of promising antiinfective
agents which have in their structures adamantane and pyridoxine moieties. Another specific reason
was to explore the ability of pyridoxine pharmacophore to suppress the potential of microbial pathogens
to develop resistance to drug molecules.
Methods:
In this study, a series of pyridoxine-adamantane and pyridoxine-cyclooctane dipharmacophore
molecules were synthesized based on reactions of three different cycloalkyl amines with the
corresponding electrophilic derivatives of pyridoxine aldehydes, chlorides and acetates. All synthesized
compounds have been tested for their in vitro activity against M. tuberculosis H37Rv strain and
H3N2 (A/Aichi/2/68) influenza virus.
Results:
Series of pyridoxine-adamantane and pyridoxine-cyclooctane dipharmacophore molecules
were synthesized based on reactions of three different cycloalkylamines with the corresponding
electrophilic derivatives of pyridoxine aldehydes, chlorides and acetates. Reaction of cycloalkylamines
with pyridoxine derivatives, in which meta-hydroxyl and ortho-hydroxymethyl groups are
protected by acetyl groups, represents a useful alternative to reductive amination of aldehydes and
nucleophilic substitution of alkyl halides. According to a tentative mechanism, it proceeds via paraand
ortho-pyridinone methides which readily react with nucleophiles. None of the synthesized dipharmacophore
compounds showed activity against M. tuberculosis H37Rv strain. At the same time,
three compounds demonstrated some antiviral activity against H3N2 (A/Aichi/2/68) influenza virus
(EC50 52-88 µg/mL) that was comparable to the activity of Amantadine, though lower than the activity
of Rimantadine. The results of this work can be useful in the design of physiologically active
derivatives of pyridoxine and adamantane.
Conclusion:
The results of this work can be useful in the design of physiologically active derivatives
of pyridoxine and adamantane.
Collapse
Affiliation(s)
- Rail Khaziev
- Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Nikita Shtyrlin
- Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Roman Pavelyev
- Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Raushan Nigmatullin
- Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Raylya Gabbasova
- Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Denis Grishaev
- Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Anna Shtro
- Laboratory for Chemotherapy of Viral Infections, Smorodintsev Research Institute of Influenza, Saint Petersburg, Russian Federation
| | - Anastasia Galochkina
- Laboratory for Chemotherapy of Viral Infections, Smorodintsev Research Institute of Influenza, Saint Petersburg, Russian Federation
| | - Yulia Nikolaeva
- Laboratory for Chemotherapy of Viral Infections, Smorodintsev Research Institute of Influenza, Saint Petersburg, Russian Federation
| | - Tatiana Vinogradova
- Saint Petersburg Research Institute of Phthisiopulmonology, Saint Petersburg, Russian Federation
| | - Olga Manicheva
- Saint Petersburg Research Institute of Phthisiopulmonology, Saint Petersburg, Russian Federation
| | - Marine Dogonadze
- Saint Petersburg Research Institute of Phthisiopulmonology, Saint Petersburg, Russian Federation
| | - Oleg Gnezdilov
- Zavoisky Physical- Technical Institute, FRC Kazan Scientific Center, RAS, Kazan, Russia; 5Saint Petersburg State University, Saint Petersburg, Russian Federation
| | - Evgenii Sokolovich
- Saint Petersburg Research Institute of Phthisiopulmonology, Saint Petersburg, Russian Federation
| | - Petr Yablonskiy
- Saint Petersburg Research Institute of Phthisiopulmonology, Saint Petersburg, Russian Federation
| | - Konstantin Balakin
- Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| | - Yurii Shtyrlin
- Scientific and Educational Center of Pharmaceutics, Kazan (Volga Region) Federal University, Kazan, Russian Federation
| |
Collapse
|
3
|
El Sayed MT, Sabry NM, Hamdy NA, Voronkov A, Ogungbe IV, Balakin K, Abdel-Aziz MS. Synthesis, Anti-Methicillin-resistant S. aureus (MRSA) Evaluation, Quantitative Structure-Activity Relationship and Molecular Modeling Studies of Some Novel Bis-indoles as Prospective MRSA Pyruvate Kinase Inhibitors. LETT DRUG DES DISCOV 2018. [DOI: 10.2174/1570180815666171213144922] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Affiliation(s)
- Mardia T. El Sayed
- Applied Organic Chemistry Department, National Research Centre, El Behous street, 12311-Dokki, Egypt
| | - Nermien M. Sabry
- Applied Organic Chemistry Department, National Research Centre, El Behous street, 12311-Dokki, Egypt
| | - Nehal A. Hamdy
- Applied Organic Chemistry Department, National Research Centre, El Behous street, 12311-Dokki, Egypt
| | - Andrey Voronkov
- Digital Bio Pharm Ltd., 145-157 St. John Street, London, EC1V 4PW, United Kingdom
| | - Ifedayo V. Ogungbe
- Department of Chemistry & Biochemistry, Jackson State University, 1400 J. R. Lynch Street, P.O. Box 17910-Jackson, MS 39217-0510, United States
| | - Konstantin Balakin
- Moscow Institute of Physic and Technology (State University), Moscow 119991, Russian Federation
| | - Mohamed S. Abdel-Aziz
- Microbial Chemistry Department, National Research Centre, El Behous street, 12311-Dokki, Egypt
| |
Collapse
|